メインコンテンツに移動
翻訳中 — お使いの言語版を準備している間、このコンテンツは英語で表示されています。

A doomsday scenario for American AI

Geopolitics
United States
September 26, 2026に開始

That is the title of my latest Free Press column, here is the closing bit: Sick and elderly Americans will go to Chinese companies for their AI-invented and AI-tested medical devices and drugs. America still will be a wealthy country, so China will charge the highest prices possible, yet prioritize Chinese citizens for treatment. Large […] The post A doomsday scenario for American AI appeared first on Marginal REVOLUTION. CommentsExcept for when there is an immediate pandemic, I find the . by...

ソース記事

Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 投票すべき主張 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 投稿者: admin • Sep 26, 2026
The U.S. must create a regulatory framework for AI in healthcare to maintain ethical standards and protect patient rights.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
American citizens should have access to affordable AI-driven healthcare solutions developed domestically.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
The U.S. government should invest heavily in AI healthcare technologies to maintain leadership and protect its citizens.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
The rise of AI in healthcare will create job losses for American healthcare professionals, leading to economic instability.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
China will prioritize its citizens over Americans in AI-driven healthcare, leading to inequality in medical treatment.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
American healthcare will decline if patients turn to foreign AI-driven medical solutions due to higher costs and lack of access.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
U.S. policymakers must address supply-chain vulnerabilities in pharmaceutical and medical device manufacturing, regardless of which country develops the underlying AI.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
Whether or not China leads in AI development, the United States must maintain transparent regulatory standards that evaluate medical treatments on safety and efficacy alone.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
Regulations must be established to ensure that AI healthcare solutions prioritize patient safety over profit.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 投稿者: admin • Sep 26, 2026
Public investment in American AI research for healthcare should be evaluated on the basis of measurable health outcomes, not nationalist competitive ranking.

翻訳準備中

Vote options for this statement: agree, disagree, or unsure
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us